![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Incidence of and predictors for direct acting antiviral treatment failure among 4099 hepatitis C genotype 1 infected adults: Real world outcomes from HCV TARGET
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Sulkowski, MS; Reddy, R; Nelson, DR, Lim, JK; Galati, JS; Kuo, A; Terrault, N; Lok, AS; Pearlman, BL; Vainorius, M; Akushevich, L; Fried, MW; Di Bisceglie, AM
![0426171](../images/042617/042617-17/0426171.gif)
![0426172](../images/042617/042617-17/0426172.gif)
![0426173](../images/042617/042617-17/0426173.gif)
![0426174](../images/042617/042617-17/0426174.gif)
![0426175](../images/042617/042617-17/0426175.gif)
![0426176](../images/042617/042617-17/0426176.gif)
![0426177](../images/042617/042617-17/0426177.gif)
![0426178](../images/042617/042617-17/0426178.gif)
Applying the inverse probability weighting (IPW) by propensity scores shows that compared to SOF/SMV±RBV patients, both LDV/SOF±RBV and PRoD±RBV patients have higher odds to achieve SVR: OR=2.63 (95% CI 2.16-3.21) and 1.92 (95%CI: 1.5-2.45), correspondingly.
All parameters used in pseudo-randomization are presented in the tables.
![0426179](../images/042617/042617-17/0426179.gif)
![04261710](../images/042617/042617-17/04261710.gif)
Applying the inverse probability weighting (IPW) by propensity scores shows that compared to SOF/SMV±RBV patients, both LDV/SOF±RBV and PRoD±RBV patients have higher odds to achieve SVR: OR=2.63 (95% CI 2.16-3.21) and 1.92 (95%CI: 1.5-2.45), correspondingly.
All parameters used in pseudo-randomization are presented in the tables.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|